• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Saturday 11/18/2017
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Medical

  • 4:09 PM

    SAN DIEGO, January 26, 2016, RGBP,/PRNewswire/ — Regen BioPharma, Inc., (OTCBB: RGBP) and (PINK: RGBP)   announced today submission to the Food and Drug Administration (FDA) of an application requesting Orphan Drug status for the use of HemaXellerate for the treatment of aplastic anemia. “Because HemaXellerate is a personalized cell therapy product aimed at addressing an unmet medical need, we are hopeful that the FDA will grant it orphan status,” said David Koos, Ph.D., Chairman and CEO of Regen BioPharma. HemaXellerate

    Read more
  • Dario Logo
    3:38 PM

    CAESAREA, Israel, January 26, 2016, DRIO, /PRNewswire/ — Sales channels to include direct-to-consumer, e-commerce, third-party distributors Establishing North American headquarters and warehouse to serve U.S. and Canada LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Blood Glucose Monitoring System, today announced it is preparing to launch its FDA-cleared product in the United States in the first quarter of 2016. The national rollout in the U.S. follows the FDA’s 510(k) clearance of the Dario in December 2015. Direct-to-consumer sales through

    Read more
  • 3:26 PM

    FRISCO, TX— OXYS, (Marketwired – January 26, 2016) – OxySure Therapeutics, Inc. (OTCQB: OXYS) (“OxySure,” or the “Company”), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen products with its “oxygen from powder” technology and other innovative medical solutions today announced that the Company has partnered with MedOne Capital, the premier leasing provider of medical equipment in the United States to provide OxySure customers easy, fast and flexible financing of medical devices. Julian Ross, Chairman and CEO

    Read more
  • 5:55 PM

    Data for review in connection with the New Drug Application to NAFDAC for use as an immune booster and adjunct treatment for Human Immunodeficiency Virus ORLANDO, FL AND DUBLIN, IRELAND / ACCESSWIRE / IMUN/ January 21, 2016 / Immune Therapeutics Inc., a U.S. public company (OTCQB: IMUN) today announced that it has completed its 90-day bridging trail of Human Immunodeficiency Virus positive [HIV+] patients and submitted data to The National Agency for Food and Drug Administration and Control, (NAFDAC) in

    Read more
  • 3:37 PM

    LOS ANGELES, Jan. 20, 2016, CATS, /PRNewswire/ — Catasys, Inc. (OTCQB: CATS), a provider of proprietary data, predictive analytics, and modeling based behavioral health management services for health plans, announced today that it has launched its OnTrak™-H solution inWisconsin with one of the nation’s leading health plans. The plan’s eligible Medicare Advantage members will be covered under OnTrak-H, a 52-week, multi-phase program in which enrolled members receive medical and psychosocial interventions, as well as intensive care coaching. “Wisconsin represents the first

    Read more
  • 3:28 PM

    Sale Expected to Release Approximately $7.5 Million in Previously Unrecognized Net Tangible Equity — Cash That Can Be Used to Support First Choice’s Growth Initiatives and Position the Company for Up-Listing to a National Stock Exchange MELBOURNE, FL, FCHS, –(Marketwired – Jan 20, 2016) – First Choice Healthcare Solutions, Inc. (OTCQB: FCHS) (“FCHS,” “First Choice” or “the Company”), one of the nation’s only non-physician-owned, publicly traded healthcare services companies focused on the delivery of Orthopaedic care and treatment, today announced

    Read more
Public Wire Banner